Clinical Trials Directory

Trials / Completed

CompletedNCT01526122

Pharmacokinetics & Safety Study of Clopidogrel 75mg and Aspirin 100mg Coadministration

A PhaseⅠ Study to Compare the Pharmacokinetic Characteristics and Safety After Oral Administration of G0041(75/100mg) With Those of Clopidogrel 75mg & Aspirin 100mg Coadministration in Healthy Male Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
65 (actual)
Sponsor
Dong-A ST Co., Ltd. · Industry
Sex
Male
Age
20 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to compare characteristics and safety after oral administration of G0041(75/100mg) 2 tablets with those of Clopidogrel 75mg 2 tablets \& Aspirin 100mg 2 capsules coadministration in healthy male volunteers.

Conditions

Interventions

TypeNameDescription
DRUGG0041(75/100mg)G0041(75/100mg) 2 capsules(Clopidogrel 75mg \& Aspirin 100mg in 1 capsule), PO
DRUGClopidogrel & AspirinClopidogrel 75mg 2 tablets \& Aspirin 100mg 2 capsules, PO

Timeline

Start date
2011-09-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2012-02-03
Last updated
2014-10-01

Source: ClinicalTrials.gov record NCT01526122. Inclusion in this directory is not an endorsement.